Search results
Ozempic maker slams Biden after the president accused the drug company of ‘ripping off’ US consumers
The Independent via Yahoo News Singapore· 4 days agoOzempic’s price “has decreased approximately 40 percent since launch and over 80 percent of...
Mounjaro leads to significantly more weight loss than Ozempic, study suggests
CNN via Yahoo News Singapore· 2 hours agoPeople taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study.
NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Zacks via Yahoo Singapore Finance· 4 days agoA new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's...
Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs
Benzinga via Yahoo Singapore Finance· 6 days agoThe President of the United States, Joe Biden, and Sen. Bernie Sanders, the Senate Chairman of the...
FDA approves a second Alzheimer's drug that can modestly slow disease
Associated Press Finance via Yahoo Singapore Finance· 6 days agoU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing...
Factbox-Stocks to watch as Biden and Trump vie for presidency
Reuters via Yahoo Singapore Finance· 5 days agoAND INSURERS UBS sees a lower risk of drug price cuts and an inclination towards Medicare Advantage...
Viking (VKTX) Skyrockets 197% YTD: Is the Stock Worth a Buy?
Zacks via Yahoo Singapore Finance· 6 days agoDespite having no marketed drugs, Viking's (VKTX) stock continues to experience robust price...
Best Performing ETFs by Sector in the Past 30 Days
Zacks via Yahoo Singapore Finance· 6 days agoMeanwhile, the big pharma companies are coming up with new drug data (read: Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?). India ETFs...
5 things to know for July 3: Presidential race, Hurricane Beryl, India crowd crush, Alzheimer’s...
CNN via Yahoo News Singapore· 5 days agoAlzheimer’s treatment The FDA on Tuesday approved a new drug to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by the pharmaceutical giant Eli
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Benzinga via Yahoo Singapore Finance· 3 days agoOn Friday, the U.K. industry body PMCPA announced that the reprimand followed a voluntary submission...